Trials / Unknown
UnknownNCT05468021
Puerto Rico COVID-19 Vaccine Uptake Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 394 (actual)
- Sponsor
- University of Puerto Rico · Academic / Other
- Sex
- All
- Age
- 21 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to recruit a total of 386 participants to evaluate the effectiveness of an educational program to increase the proportion of men and women aged 21 years and older who have received the COVID-19 booster vaccine
Detailed description
This study will address vaccine hesitancy, evaluating the intervention's efficacy in a group of vulnerable and economically disadvantaged population in PR. Randomized Clinical Trial (study design) to evaluate the effectiveness of an educational intervention to increase vaccine uptake among socioeconomically disadvantaged adults. A total sample of 386 participants will be recruited. The duration of the study will consist of 1.5 hours for intervention group and 1 hour for control group. Eligibility criteria for the study include the following: (1) age 21 years and older, (2) resident of Puerto Rico, (3) to be fully vaccinated (received the one-dose Jansen/Johnson \& Johnson vaccine, -OR- received both doses of the two-dose Pfizer or Moderna vaccine), have not received booster doses against COVID-19, (4) no history of allergic reactions to any vaccine, (5) no history of mental health conditions that impede participation in the study, and (6) able to read, write, and understand Spanish.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Educational intervention | Randomized Clinical Trial (study design) to evaluate the effectiveness of an educational intervention to increase vaccine uptake among socioeconomically disadvantaged adults. The intervention will consist of a health promoter with an educational toolkit addressing misinformation, distrust, and hesitancy regarding the COVID-19 vaccine. An educational website with videos addressing COVID-19 vaccine will be available to study participants to boost information provided in the educational toolkit. |
Timeline
- Start date
- 2022-06-26
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
- First posted
- 2022-07-21
- Last updated
- 2022-12-16
Locations
2 sites across 1 country: Puerto Rico
Source: ClinicalTrials.gov record NCT05468021. Inclusion in this directory is not an endorsement.